Infliximab-induced psoriasis during therapy for Crohn's disease
Nenhuma Miniatura disponível
Data
2012-06-01
Autores
Steinwurz, Flavio
Denadai, Rafael [UNESP]
Saad-Hossne, Rogerio [UNESP]
Queiroz, Maria Luiza
Teixeira, Fabio Vieira [UNESP]
Romiti, Ricardo
Título da Revista
ISSN da Revista
Título de Volume
Editor
Elsevier B.V.
Resumo
Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, mostly in the setting of rheumatologic diseases. To date, less than 50 cases of infliximab-induced psoriasis in inflammatory bowel disease patients have been described. The present report was aimed at describing two new cases of infliximab-induced psoriasis during therapy for Crohn's disease and at carrying out a review on this intriguing phenomenon. (C) 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
Descrição
Palavras-chave
Biological therapy, Crohn's disease, Infliximab, Psoriasis, Tumor necrosis factor-alpha inhibitors
Como citar
Journal of Crohns & Colitis. Amsterdam: Elsevier B.V., v. 6, n. 5, p. 610-616, 2012.